Study Stopped
difficulty in performing study
The Prognosis of Graft Using Plastic Cannula in Hemodialysis
A Prospective Study of the Prognosis of Graft With Plastic Cannula in Hemodialysis
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this study is to evaluate the complication of the puncture related complication in AVG (arteriovenous graft) such as pseudoaneurysm and hematoma, and the dialysis adequacy using plastic cannula versus metal needle in hemodialysis patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 21, 2018
CompletedFirst Posted
Study publicly available on registry
August 24, 2018
CompletedStudy Start
First participant enrolled
October 22, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2019
CompletedAugust 3, 2022
August 1, 2022
6 months
August 21, 2018
August 1, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of pseudoaneurysm
critical puncture related complication in AVG
Incidence of pseudoaneurysm at 6 months
Secondary Outcomes (2)
punctutre related complication
Monthly for 6 months.
Dialysis adeqaucy
Monthly for 6 months.
Study Arms (2)
Metal needle gruop
NO INTERVENTIONpuncture using metal needle
plastic cannula
EXPERIMENTALpuncture using plastic cannula
Interventions
Eligibility Criteria
You may qualify if:
- Patients receiving hemodialysis treatment using AVG
You may not qualify if:
- Age under 20 years old or over 75 years old
- Abnormal skin condition using immunosuppressants such as steroids.
- Skin disorder
- Metal allergy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hallym University Sacred Heart Hospital
Anyang-si, Gyeonggi-do, 14066, South Korea
Study Officials
- PRINCIPAL INVESTIGATOR
Sun Ryoung Choi, MD,PhD
Hallym University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
August 21, 2018
First Posted
August 24, 2018
Study Start
October 22, 2018
Primary Completion
May 1, 2019
Study Completion
June 1, 2019
Last Updated
August 3, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share